Literature DB >> 25683948

Review of new hypertension guidelines.

P-Y Zhang1.   

Abstract

The Eighth Joint National Committee (JNC 8) released its new guidelines on the management of adult hypertension in Dec 2013. The key departures from JNC 7 include target blood pressures and thresholds for initiation of elderly patients and in patients under age 60 with diabetes and kidney disease. In this review, we analyse the critical questions, basis of new recommendations, major deviations from JNC 7, the strengths and limitations of changes in previous management guidelines.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25683948

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

1.  Pharmacokinetics and bioequivalence of fixed-dose combination of candesartan cilexetil/amlodipine besylate (16/10 mg) versus coadministration of individual formulations in healthy subjects.

Authors:  Hae Won Lee; Woo Youl Kang; Wookjae Jung; Mi-Ri Gwon; Dong Heon Yang; Eun Hee Kim; Kyunghee Cho; Young-Ran Yoon; Sook Jin Seong
Journal:  Transl Clin Pharmacol       Date:  2020-06-24

2.  Dietary amino acids and incidence of hypertension: A principle component analysis approach.

Authors:  Farshad Teymoori; Golaleh Asghari; Parvin Mirmiran; Fereidoun Azizi
Journal:  Sci Rep       Date:  2017-12-04       Impact factor: 4.379

3.  Hypertension and Diabetes Mellitus: How Do They Affect the Right Ventricular Functions Individually and Together?

Authors:  Inas Ibrahim Eweda
Journal:  J Cardiovasc Echogr       Date:  2017 Jul-Sep

4.  Replication of European hypertension associations in a case-control study of 9,534 African Americans.

Authors:  Harpreet Kaur; Dana C Crawford; Jingjing Liang; Penelope Benchek; Xiaofeng Zhu; Asha R Kallianpur; William S Bush
Journal:  PLoS One       Date:  2021-11-18       Impact factor: 3.240

5.  Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects.

Authors:  Woo Youl Kang; Sook Jin Seong; Boram Ohk; Mi-Ri Gwon; Bo Kyung Kim; Sookie La; Hyun-Ju Kim; Seungil Cho; Young-Ran Yoon; Dong Heon Yang; Hae Won Lee
Journal:  Drug Des Devel Ther       Date:  2018-03-14       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.